Experiment 361013

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismCimicifuga racemosa (RANUNCULACEAE)
CitationANON:. (1996). HRT VS. REMIFEMIN IN MENOPAUSE.. 3(4)
Amount utilized
Compound isolated
DiseaseAN OPEN STUDY TO ASSESS THE EFFECTIVENESS OF CIMICIFUGA RACEMOSA IN THE TREATMENT OF MENOPAUSE IN 629 PATIENTS. TWO TABLETS (40 MG) TWICE A DAY IMPROVED THE FOLLOWING SYMPTOMS AFTER 4 WEEKS: HOT FLASHES, HEADACHE, VERTIGO, TINNITIS, NERVOUSNESS, SLEEP DISTURBANCES, AND DEPRESSIVE MOODS. ONLY 7% OF PATIENTS HAD MILD STOMACH COMPLAINTS.
Dose amount160.0 MG
Number2
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitDAY
Dose expressionDOSE
ExtractRHIZOME + ROOT
GenderFEMALE